[Results using ciclacillin with special reference to tolerance and adverse effects].
D001660:Biliary Tract Diseases / Q000188:drug therapy; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology; D004361:Drug Tolerance; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D010397:Penicillanic Acid / Q000009:adverse effects / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects* / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D003510:Cyclohexanes; D010406:Penicillins; D010397:Penicillanic Acid
Erfahrungen mit Ciclacillin mit besonderer Berücksichtigung der Verträglichkeit und Nebenwirkungen.